+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

HIV and HBV Therapies Market Report 2022-2032 - Product Thumbnail Image

HIV and HBV Therapies Market Report 2022-2032

  • Report
  • November 2022
  • 353 Pages
  • Global
From
From
Breast Cancer Monoclonal Antibodies Market 2024-2028 - Product Thumbnail Image

Breast Cancer Monoclonal Antibodies Market 2024-2028

  • Report
  • July 2024
  • 182 Pages
  • Global
From
Hepatitis Therapeutics Market Report 2025 - Product Thumbnail Image

Hepatitis Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatitis Drugs Market Report 2025 - Product Thumbnail Image

Hepatitis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Axial Spondyloarthritis (AxSpA) Market Report 2025 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market 2024-2028 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • September 2024
  • 156 Pages
  • Global
From
From
From
Psoriatic Arthritis Treatment Market Report 2025 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Report
  • April 2025
  • 180 Pages
  • Global
From
From
Loading Indicator